Detalhe da pesquisa
1.
Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation.
J Neurosci
; 23(9): 3745-51, 2003 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12736345